A very rare case of encephalopathy in a patient with end-stage renal disease: contrast agent, ioversol.
Contrast agents are associated with a number of adverse effects, including central nervous system effects. These agents are primarily filtered and excreted by the kidney. Contrast-associated encephalopathy is a rare complication. We report the case of a 55-year-old male on chronic hemodialysis who developed confusion and agitation after receiving ioversol during abdominal angiography. Although hemodialysis was performed his healing took 15 days. Patients with end-stage renal disease may be at an increased risk of adverse effects of contrast agents.
Ozelsancak
Ruya
R
Department of Nephrology, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Adana, Turkey. rusancak@hotmail.com
Erken
Ertugrul
E
Yildiz
Ismail
I
Giray
Semih
S
Yildirim
Tulin
T
Micozkadioglu
Hasan
H
D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D014283:Triiodobenzoic Acids / Q000009:adverse effects*
D003287:Contrast Media; D014283:Triiodobenzoic Acids; C054871:ioversol